Delve into the STAT6 degrader technology and what it could bring to inflammatory and allergic disease treatment.

Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a ...

Discover six kidney disease companies actively working on innovative treatments that could make a difference to patients' lives.

On the occasion of its deal with Cure51, find out about NVIDIA's biotech strategy as it gets more and more involved in the ...

Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for ...